Cosmos Health shareholders elect directors, approve Series B Preferred Stock and 2026 Equity Plan at annual meeting

Cosmos Health Inc.

All six director nominees elected with 79-84% affirmative votes.
Ratification of independent auditor approved with 84.24% affirmative.
2026 Equity Omnibus Plan approved with 79.58% affirmative.
Issuance of 100,000 shares of Series B Preferred Stock approved with 78.98% affirmative.
Approximately 47% of outstanding shares voted at the meeting.

item 3.03 item 5.03 item 5.02 item 5.07 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.